Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Sweden Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20083
20093
20102
20121
20132
20151
20161
20171
20192
20201
20215
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated3
Active, not recruiting2
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion8
United Therapeutics5
Bayer3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Cereno Scientific AB2
Merck Sharp & Dohme LLC2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Aerovate Therapeutics1
GlaxoSmithKline1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension28
Hypertension, Pulmonary10
Hypertension3
Cardiovascular Diseases2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.